

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.36628753 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.97819993 |
| 3 | cellular ketone body metabolic process (GO:0046950) | 4.74167204 |
| 4 | ATP synthesis coupled proton transport (GO:0015986) | 4.66080429 |
| 5 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.66080429 |
| 6 | respiratory electron transport chain (GO:0022904) | 4.57692062 |
| 7 | electron transport chain (GO:0022900) | 4.54315201 |
| 8 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 4.54312001 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.52690091 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.52690091 |
| 11 | respiratory chain complex IV assembly (GO:0008535) | 4.43819815 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.35190864 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.35190864 |
| 14 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.28431106 |
| 15 | ketone body metabolic process (GO:1902224) | 4.24313010 |
| 16 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.22697104 |
| 17 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.13428477 |
| 18 | cytochrome complex assembly (GO:0017004) | 4.11155171 |
| 19 | peptide hormone processing (GO:0016486) | 3.79728893 |
| 20 | inositol phosphate dephosphorylation (GO:0046855) | 3.74159715 |
| 21 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.74159715 |
| 22 | inositol phosphate catabolic process (GO:0071545) | 3.72008477 |
| 23 | endocrine pancreas development (GO:0031018) | 3.67742302 |
| 24 | nitric oxide biosynthetic process (GO:0006809) | 3.66247653 |
| 25 | protein neddylation (GO:0045116) | 3.64814085 |
| 26 | retinol metabolic process (GO:0042572) | 3.64604476 |
| 27 | auditory receptor cell differentiation (GO:0042491) | 3.63510687 |
| 28 | insulin secretion (GO:0030073) | 3.59450867 |
| 29 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.54656830 |
| 30 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.54656830 |
| 31 | hydrogen ion transmembrane transport (GO:1902600) | 3.48044894 |
| 32 | xenobiotic catabolic process (GO:0042178) | 3.45493152 |
| 33 | phenol-containing compound catabolic process (GO:0019336) | 3.43865878 |
| 34 | signal peptide processing (GO:0006465) | 3.40585645 |
| 35 | positive regulation of gluconeogenesis (GO:0045722) | 3.27209736 |
| 36 | sensory perception of smell (GO:0007608) | 3.24943264 |
| 37 | glycerophospholipid catabolic process (GO:0046475) | 3.21288922 |
| 38 | regulation of extracellular matrix disassembly (GO:0010715) | 3.19835428 |
| 39 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.19825964 |
| 40 | positive regulation of insulin secretion (GO:0032024) | 3.18153954 |
| 41 | intestinal epithelial cell development (GO:0060576) | 3.14391101 |
| 42 | proton transport (GO:0015992) | 3.12432028 |
| 43 | ATP biosynthetic process (GO:0006754) | 3.11839200 |
| 44 | epithelial cell fate commitment (GO:0072148) | 3.10804459 |
| 45 | regulation of hexokinase activity (GO:1903299) | 3.09695609 |
| 46 | regulation of glucokinase activity (GO:0033131) | 3.09695609 |
| 47 | sphingomyelin metabolic process (GO:0006684) | 3.09003592 |
| 48 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.08507613 |
| 49 | hydrogen transport (GO:0006818) | 3.06537337 |
| 50 | GDP-mannose metabolic process (GO:0019673) | 3.06110427 |
| 51 | central nervous system myelination (GO:0022010) | 3.03791035 |
| 52 | axon ensheathment in central nervous system (GO:0032291) | 3.03791035 |
| 53 | glandular epithelial cell differentiation (GO:0002067) | 3.01764182 |
| 54 | positive regulation of calcium ion import (GO:0090280) | 3.00302217 |
| 55 | NADH metabolic process (GO:0006734) | 2.98174764 |
| 56 | glutathione derivative biosynthetic process (GO:1901687) | 2.96727717 |
| 57 | glutathione derivative metabolic process (GO:1901685) | 2.96727717 |
| 58 | polyol catabolic process (GO:0046174) | 2.95568403 |
| 59 | macroautophagy (GO:0016236) | 2.95452251 |
| 60 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.93633652 |
| 61 | neuronal action potential (GO:0019228) | 2.92321512 |
| 62 | negative regulation of complement activation (GO:0045916) | 2.90459476 |
| 63 | C-terminal protein lipidation (GO:0006501) | 2.90412144 |
| 64 | potassium ion export (GO:0071435) | 2.86793639 |
| 65 | protein complex biogenesis (GO:0070271) | 2.86587963 |
| 66 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.85862121 |
| 67 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.85132163 |
| 68 | platelet dense granule organization (GO:0060155) | 2.81589988 |
| 69 | nitric oxide mediated signal transduction (GO:0007263) | 2.80429291 |
| 70 | glutathione biosynthetic process (GO:0006750) | 2.79493362 |
| 71 | regulation of oxidative phosphorylation (GO:0002082) | 2.78249477 |
| 72 | detection of calcium ion (GO:0005513) | 2.78230451 |
| 73 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.76408106 |
| 74 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.76408106 |
| 75 | transferrin transport (GO:0033572) | 2.76293653 |
| 76 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.75150460 |
| 77 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.74004702 |
| 78 | protein localization to cilium (GO:0061512) | 2.72814923 |
| 79 | phenylpropanoid metabolic process (GO:0009698) | 2.72273544 |
| 80 | epithelial cilium movement (GO:0003351) | 2.71455422 |
| 81 | inositol phosphate-mediated signaling (GO:0048016) | 2.71098236 |
| 82 | oxidative phosphorylation (GO:0006119) | 2.70115732 |
| 83 | dopamine biosynthetic process (GO:0042416) | 2.69771138 |
| 84 | peptide hormone secretion (GO:0030072) | 2.69590842 |
| 85 | regulation of autophagic vacuole assembly (GO:2000785) | 2.69448846 |
| 86 | inner mitochondrial membrane organization (GO:0007007) | 2.69083874 |
| 87 | aromatic amino acid family catabolic process (GO:0009074) | 2.68656486 |
| 88 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.68332912 |
| 89 | phosphatidylserine metabolic process (GO:0006658) | 2.65286589 |
| 90 | peptide secretion (GO:0002790) | 2.64853575 |
| 91 | glucosamine-containing compound catabolic process (GO:1901072) | 2.64416934 |
| 92 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.63614401 |
| 93 | axoneme assembly (GO:0035082) | 2.62128300 |
| 94 | C-terminal protein amino acid modification (GO:0018410) | 2.61781909 |
| 95 | positive regulation of peptide hormone secretion (GO:0090277) | 2.60559198 |
| 96 | trivalent inorganic cation transport (GO:0072512) | 2.60183544 |
| 97 | ferric iron transport (GO:0015682) | 2.60183544 |
| 98 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.57830326 |
| 99 | succinate metabolic process (GO:0006105) | 2.56804732 |
| 100 | response to water (GO:0009415) | 2.56580361 |
| 101 | primary alcohol metabolic process (GO:0034308) | 2.54223167 |
| 102 | negative regulation of protein activation cascade (GO:2000258) | 2.54097629 |
| 103 | lactate metabolic process (GO:0006089) | 2.53322532 |
| 104 | regulation of guanylate cyclase activity (GO:0031282) | 2.52448411 |
| 105 | chaperone-mediated protein transport (GO:0072321) | 2.51600766 |
| 106 | neurotransmitter catabolic process (GO:0042135) | 2.51244985 |
| 107 | sensory perception of chemical stimulus (GO:0007606) | 2.50948083 |
| 108 | regulation of execution phase of apoptosis (GO:1900117) | 2.50941245 |
| 109 | keratinocyte development (GO:0003334) | 2.50237380 |
| 110 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.49387402 |
| 111 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.49184539 |
| 112 | positive regulation of peptide secretion (GO:0002793) | 2.48766355 |
| 113 | nodal signaling pathway (GO:0038092) | 2.47437565 |
| 114 | regulation of vacuole organization (GO:0044088) | 2.47328837 |
| 115 | negative regulation of microtubule polymerization (GO:0031115) | 2.47199192 |
| 116 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.46483056 |
| 117 | membrane repolarization during action potential (GO:0086011) | 2.46061654 |
| 118 | NADH dehydrogenase complex assembly (GO:0010257) | 2.45813630 |
| 119 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.45813630 |
| 120 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.45813630 |
| 121 | cytidine metabolic process (GO:0046087) | 2.45634751 |
| 122 | cytidine catabolic process (GO:0006216) | 2.45634751 |
| 123 | cytidine deamination (GO:0009972) | 2.45634751 |
| 124 | catechol-containing compound biosynthetic process (GO:0009713) | 2.43731229 |
| 125 | catecholamine biosynthetic process (GO:0042423) | 2.43731229 |
| 126 | positive regulation of TOR signaling (GO:0032008) | 2.43212031 |
| 127 | regulation of mitochondrial translation (GO:0070129) | 2.42293409 |
| 128 | regulation of cilium movement (GO:0003352) | 2.42071707 |
| 129 | regulation of protein targeting to membrane (GO:0090313) | 2.41623121 |
| 130 | alditol phosphate metabolic process (GO:0052646) | 2.41596525 |
| 131 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.41179831 |
| 132 | cilium movement (GO:0003341) | 2.41171079 |
| 133 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.40463912 |
| 134 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.40463912 |
| 135 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.38836531 |
| 136 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.38466693 |
| 137 | peptide transport (GO:0015833) | 2.38147973 |
| 138 | neurotransmitter biosynthetic process (GO:0042136) | 2.37284912 |
| 139 | regulation of insulin secretion (GO:0050796) | 2.36530235 |
| 140 | ER overload response (GO:0006983) | 2.36240866 |
| 141 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.35789185 |
| 142 | peptide biosynthetic process (GO:0043043) | 2.35417205 |
| 143 | negative regulation of humoral immune response (GO:0002921) | 2.35090223 |
| 144 | peptide metabolic process (GO:0006518) | 2.34720460 |
| 145 | positive regulation of glycolytic process (GO:0045821) | 2.34543804 |
| 146 | cobalamin metabolic process (GO:0009235) | 2.33614328 |
| 147 | basic amino acid transport (GO:0015802) | 2.33354871 |
| 148 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.32973564 |
| 149 | establishment of melanosome localization (GO:0032401) | 2.32021283 |
| 150 | melanosome transport (GO:0032402) | 2.31270703 |
| 151 | digestion (GO:0007586) | 2.30491762 |
| 152 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.30071150 |
| 153 | actin filament depolymerization (GO:0030042) | 2.29114813 |
| 154 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.28761930 |
| 155 | action potential (GO:0001508) | 2.27293446 |
| 156 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.26841980 |
| 157 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.26433545 |
| 158 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.24299704 |
| 159 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.24115851 |
| 160 | cell communication involved in cardiac conduction (GO:0086065) | 2.21657954 |
| 161 | magnesium ion transport (GO:0015693) | 2.20774708 |
| 162 | establishment of pigment granule localization (GO:0051905) | 2.20632678 |
| 163 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.19619792 |
| 164 | pigment granule transport (GO:0051904) | 2.19375525 |
| 165 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.18836594 |
| 166 | regulation of protein glycosylation (GO:0060049) | 2.17756460 |
| 167 | monovalent inorganic cation transport (GO:0015672) | 2.17151419 |
| 168 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.16753220 |
| 169 | membrane budding (GO:0006900) | 2.16584297 |
| 170 | dopamine metabolic process (GO:0042417) | 2.16312886 |
| 171 | tricarboxylic acid cycle (GO:0006099) | 2.15547408 |
| 172 | neuron cell-cell adhesion (GO:0007158) | 2.14236546 |
| 173 | oligosaccharide catabolic process (GO:0009313) | 2.14214069 |
| 174 | positive regulation of protein targeting to membrane (GO:0090314) | 2.13966413 |
| 175 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.13700469 |
| 176 | intraciliary transport (GO:0042073) | 2.13478045 |
| 177 | negative regulation of cation channel activity (GO:2001258) | 2.13103803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.91921022 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.76052561 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51784670 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.45169780 |
| 5 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.13792070 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.12915963 |
| 7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.98398045 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.94631710 |
| 9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77106563 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.75543385 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.75361239 |
| 12 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.69168468 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.65504922 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.61963853 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.60444206 |
| 16 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.60160218 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.57785311 |
| 18 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56600829 |
| 19 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.55300635 |
| 20 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54954014 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.52612334 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50696010 |
| 23 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.49692014 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48584798 |
| 25 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.43959178 |
| 26 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.43707858 |
| 27 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.43707858 |
| 28 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.43646949 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43548756 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43275235 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42212107 |
| 32 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.41775842 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.41627527 |
| 34 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40585193 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.39238844 |
| 36 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39140611 |
| 37 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.36288365 |
| 38 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.33799855 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32717779 |
| 40 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.31977056 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.31905514 |
| 42 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30678740 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29252885 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28865095 |
| 45 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28061584 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27388419 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27069762 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.26232389 |
| 49 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.25942705 |
| 50 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.25471412 |
| 51 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.25227174 |
| 52 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.25107492 |
| 53 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.24670048 |
| 54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.24096145 |
| 55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23117352 |
| 56 | AR_20517297_ChIP-Seq_VCAP_Human | 1.22083734 |
| 57 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20938480 |
| 58 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.20888057 |
| 59 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19604591 |
| 60 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18631856 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18581711 |
| 62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17340111 |
| 63 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.17095078 |
| 64 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.17095078 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17077497 |
| 66 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16140037 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16033216 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.15568528 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15117286 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15076385 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15011515 |
| 72 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.13977180 |
| 73 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.13568171 |
| 74 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13139936 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12009876 |
| 76 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11766743 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11271511 |
| 78 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.11038114 |
| 79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.10813308 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10535680 |
| 81 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10429047 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09656118 |
| 83 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09453571 |
| 84 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.08685748 |
| 85 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.08625247 |
| 86 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08525155 |
| 87 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08009941 |
| 88 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08009941 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06623235 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.06316640 |
| 91 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06238911 |
| 92 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05406821 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05152252 |
| 94 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.05116045 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.04965391 |
| 96 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.04789710 |
| 97 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.04419531 |
| 98 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03800437 |
| 99 | NFYB_21822215_ChIP-Seq_K562_Human | 1.02661232 |
| 100 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02475283 |
| 101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02147527 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.01786229 |
| 103 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.01779624 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01139643 |
| 105 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.00908453 |
| 106 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00904013 |
| 107 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00176375 |
| 108 | STAT3_23295773_ChIP-Seq_U87_Human | 0.99856907 |
| 109 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.99539039 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99485947 |
| 111 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.99378061 |
| 112 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98843697 |
| 113 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98635489 |
| 114 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97168478 |
| 115 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.96559267 |
| 116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.96111450 |
| 117 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.95926647 |
| 118 | TBL1_22424771_ChIP-Seq_293T_Human | 0.95727426 |
| 119 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.95274698 |
| 120 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.95211587 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.95180338 |
| 122 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95059747 |
| 123 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94399903 |
| 124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.93888036 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92661940 |
| 126 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.92286734 |
| 127 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.91463276 |
| 128 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.91463276 |
| 129 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90399035 |
| 130 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89601748 |
| 131 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89388494 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89336053 |
| 133 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89137875 |
| 134 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.88679077 |
| 135 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.87842779 |
| 136 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.87767874 |
| 137 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87696318 |
| 138 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87229875 |
| 139 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.85456784 |
| 140 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85454606 |
| 141 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85115545 |
| 142 | NCOR_22424771_ChIP-Seq_293T_Human | 0.83340540 |
| 143 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83278834 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83192293 |
| 145 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.82640491 |
| 146 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.82571360 |
| 147 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82490291 |
| 148 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82209884 |
| 149 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81867371 |
| 150 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.81212296 |
| 151 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81045367 |
| 152 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80938267 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80916889 |
| 154 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.80890192 |
| 155 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.79742318 |
| 156 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79109884 |
| 157 | P300_19829295_ChIP-Seq_ESCs_Human | 0.78697162 |
| 158 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78695275 |
| 159 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78212946 |
| 160 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.76849185 |
| 161 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76340035 |
| 162 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.76323575 |
| 163 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.75731684 |
| 164 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.75108280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.40940873 |
| 2 | MP0005379_endocrine/exocrine_gland_phen | 3.82804575 |
| 3 | MP0002822_catalepsy | 3.30016267 |
| 4 | MP0004270_analgesia | 3.19640310 |
| 5 | MP0002163_abnormal_gland_morphology | 3.08935009 |
| 6 | MP0004043_abnormal_pH_regulation | 3.05882753 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.70983090 |
| 8 | MP0001984_abnormal_olfaction | 2.64531209 |
| 9 | MP0002734_abnormal_mechanical_nocicepti | 2.44712712 |
| 10 | MP0001944_abnormal_pancreas_morphology | 2.42755160 |
| 11 | MP0003878_abnormal_ear_physiology | 2.33047490 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 2.33047490 |
| 13 | MP0008004_abnormal_stomach_pH | 2.33038055 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.32217244 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.19275692 |
| 16 | MP0002693_abnormal_pancreas_physiology | 2.16366493 |
| 17 | MP0002254_reproductive_system_inflammat | 2.12578221 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.07342292 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 2.06718258 |
| 20 | MP0005365_abnormal_bile_salt | 2.04712537 |
| 21 | MP0001664_abnormal_digestion | 2.03670166 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.02280142 |
| 23 | MP0002736_abnormal_nociception_after | 2.00344284 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.95930396 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.95171600 |
| 26 | MP0001970_abnormal_pain_threshold | 1.88344536 |
| 27 | MP0001529_abnormal_vocalization | 1.86093237 |
| 28 | MP0003011_delayed_dark_adaptation | 1.84964808 |
| 29 | MP0001905_abnormal_dopamine_level | 1.80243313 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.79016601 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77828608 |
| 32 | MP0004858_abnormal_nervous_system | 1.74863268 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.74773527 |
| 34 | MP0000462_abnormal_digestive_system | 1.72086130 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.71733313 |
| 36 | MP0001986_abnormal_taste_sensitivity | 1.70605321 |
| 37 | MP0005645_abnormal_hypothalamus_physiol | 1.69595888 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.65728840 |
| 39 | MP0002272_abnormal_nervous_system | 1.64295061 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.63287399 |
| 41 | MP0002078_abnormal_glucose_homeostasis | 1.58178711 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.56946579 |
| 43 | MP0001756_abnormal_urination | 1.56383372 |
| 44 | MP0003186_abnormal_redox_activity | 1.54006774 |
| 45 | MP0008260_abnormal_autophagy | 1.50519992 |
| 46 | MP0000372_irregular_coat_pigmentation | 1.49433044 |
| 47 | MP0005220_abnormal_exocrine_pancreas | 1.48046459 |
| 48 | MP0001765_abnormal_ion_homeostasis | 1.46810610 |
| 49 | MP0003195_calcinosis | 1.44051538 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.42908559 |
| 51 | MP0002909_abnormal_adrenal_gland | 1.42438718 |
| 52 | MP0003787_abnormal_imprinting | 1.41194220 |
| 53 | MP0001666_abnormal_nutrient_absorption | 1.40248547 |
| 54 | MP0003880_abnormal_central_pattern | 1.39457049 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.34497089 |
| 56 | MP0008789_abnormal_olfactory_epithelium | 1.34309758 |
| 57 | MP0003879_abnormal_hair_cell | 1.30348686 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.29078956 |
| 59 | MP0001542_abnormal_bone_strength | 1.28537294 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.25639457 |
| 61 | MP0002064_seizures | 1.25109540 |
| 62 | MP0005535_abnormal_body_temperature | 1.24937606 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.24923520 |
| 64 | MP0002184_abnormal_innervation | 1.23655214 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.22792102 |
| 66 | MP0005551_abnormal_eye_electrophysiolog | 1.22765287 |
| 67 | MP0005448_abnormal_energy_balance | 1.21600120 |
| 68 | MP0003252_abnormal_bile_duct | 1.20065044 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.19062149 |
| 70 | MP0006036_abnormal_mitochondrial_physio | 1.18971501 |
| 71 | MP0005636_abnormal_mineral_homeostasis | 1.18864740 |
| 72 | MP0009745_abnormal_behavioral_response | 1.18852234 |
| 73 | MP0003953_abnormal_hormone_level | 1.18817240 |
| 74 | MP0005174_abnormal_tail_pigmentation | 1.18803442 |
| 75 | MP0004147_increased_porphyrin_level | 1.18328828 |
| 76 | MP0002067_abnormal_sensory_capabilities | 1.17989449 |
| 77 | MP0001764_abnormal_homeostasis | 1.17379350 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.17322604 |
| 79 | MP0003635_abnormal_synaptic_transmissio | 1.17275082 |
| 80 | MP0005332_abnormal_amino_acid | 1.16162743 |
| 81 | MP0004885_abnormal_endolymph | 1.16029767 |
| 82 | MP0003183_abnormal_peptide_metabolism | 1.13015848 |
| 83 | MP0006082_CNS_inflammation | 1.11324521 |
| 84 | MP0004742_abnormal_vestibular_system | 1.11092800 |
| 85 | MP0008877_abnormal_DNA_methylation | 1.10278913 |
| 86 | MP0002572_abnormal_emotion/affect_behav | 1.09686873 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 1.09586478 |
| 88 | MP0002090_abnormal_vision | 1.09515986 |
| 89 | MP0009046_muscle_twitch | 1.08610421 |
| 90 | MP0005394_taste/olfaction_phenotype | 1.08222979 |
| 91 | MP0005499_abnormal_olfactory_system | 1.08222979 |
| 92 | MP0003329_amyloid_beta_deposits | 1.07748685 |
| 93 | MP0003283_abnormal_digestive_organ | 1.07661659 |
| 94 | MP0009780_abnormal_chondrocyte_physiolo | 1.06801255 |
| 95 | MP0005253_abnormal_eye_physiology | 1.06002994 |
| 96 | MP0004036_abnormal_muscle_relaxation | 1.04200295 |
| 97 | MP0002229_neurodegeneration | 1.02373189 |
| 98 | MP0000751_myopathy | 1.01448136 |
| 99 | MP0002751_abnormal_autonomic_nervous | 1.00279068 |
| 100 | MP0005386_behavior/neurological_phenoty | 0.99509623 |
| 101 | MP0004924_abnormal_behavior | 0.99509623 |
| 102 | MP0005408_hypopigmentation | 0.99025363 |
| 103 | MP0003122_maternal_imprinting | 0.98547534 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 0.98282111 |
| 105 | MP0003315_abnormal_perineum_morphology | 0.98012544 |
| 106 | MP0001501_abnormal_sleep_pattern | 0.97590161 |
| 107 | MP0000537_abnormal_urethra_morphology | 0.97156440 |
| 108 | MP0005646_abnormal_pituitary_gland | 0.96990916 |
| 109 | MP0010678_abnormal_skin_adnexa | 0.96985395 |
| 110 | MP0004133_heterotaxia | 0.96659758 |
| 111 | MP0005410_abnormal_fertilization | 0.96577145 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.95615259 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 0.95455037 |
| 114 | MP0004215_abnormal_myocardial_fiber | 0.95442579 |
| 115 | MP0008872_abnormal_physiological_respon | 0.95233942 |
| 116 | MP0000639_abnormal_adrenal_gland | 0.93911676 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.93865779 |
| 118 | MP0002928_abnormal_bile_duct | 0.92625706 |
| 119 | MP0002160_abnormal_reproductive_system | 0.92606246 |
| 120 | MP0000749_muscle_degeneration | 0.92277476 |
| 121 | MP0004484_altered_response_of | 0.90939291 |
| 122 | MP0002063_abnormal_learning/memory/cond | 0.90433130 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.89898941 |
| 124 | MP0005248_abnormal_Harderian_gland | 0.89896595 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.89805580 |
| 126 | MP0001486_abnormal_startle_reflex | 0.89337208 |
| 127 | MP0002295_abnormal_pulmonary_circulatio | 0.88309051 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.88234647 |
| 129 | MP0009840_abnormal_foam_cell | 0.87127326 |
| 130 | MP0000747_muscle_weakness | 0.87079679 |
| 131 | MP0003866_abnormal_defecation | 0.86829990 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.86559757 |
| 133 | MP0002938_white_spotting | 0.86515965 |
| 134 | MP0000015_abnormal_ear_pigmentation | 0.83980655 |
| 135 | MP0006072_abnormal_retinal_apoptosis | 0.82332517 |
| 136 | MP0003633_abnormal_nervous_system | 0.81012557 |
| 137 | MP0000778_abnormal_nervous_system | 0.80878350 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.80536672 |
| 139 | MP0002882_abnormal_neuron_morphology | 0.80496260 |
| 140 | MP0001188_hyperpigmentation | 0.80432699 |
| 141 | MP0004142_abnormal_muscle_tone | 0.79714730 |
| 142 | MP0005075_abnormal_melanosome_morpholog | 0.79078282 |
| 143 | MP0003634_abnormal_glial_cell | 0.77512600 |
| 144 | MP0000230_abnormal_systemic_arterial | 0.77223959 |
| 145 | MP0005319_abnormal_enzyme/_coenzyme | 0.77057780 |
| 146 | MP0004085_abnormal_heartbeat | 0.75932088 |
| 147 | MP0003646_muscle_fatigue | 0.74651739 |
| 148 | MP0002971_abnormal_brown_adipose | 0.73642772 |
| 149 | MP0000427_abnormal_hair_cycle | 0.67350532 |
| 150 | MP0009642_abnormal_blood_homeostasis | 0.65536977 |
| 151 | MP0005452_abnormal_adipose_tissue | 0.63183833 |
| 152 | MP0002136_abnormal_kidney_physiology | 0.62734019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.95972374 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.68440514 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.28249505 |
| 4 | Acute encephalopathy (HP:0006846) | 4.08770524 |
| 5 | Progressive macrocephaly (HP:0004481) | 3.97242245 |
| 6 | Hypothermia (HP:0002045) | 3.87342560 |
| 7 | Mitochondrial inheritance (HP:0001427) | 3.78923629 |
| 8 | Pheochromocytoma (HP:0002666) | 3.56510854 |
| 9 | Myokymia (HP:0002411) | 3.53157434 |
| 10 | Neuroendocrine neoplasm (HP:0100634) | 3.28715903 |
| 11 | Double outlet right ventricle (HP:0001719) | 3.23047184 |
| 12 | Congenital malformation of the right heart (HP:0011723) | 3.23047184 |
| 13 | Increased CSF lactate (HP:0002490) | 3.22272698 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 3.18809776 |
| 15 | Gout (HP:0001997) | 3.17593707 |
| 16 | Hepatocellular necrosis (HP:0001404) | 3.17042685 |
| 17 | Increased CSF protein (HP:0002922) | 3.05674041 |
| 18 | Large for gestational age (HP:0001520) | 3.02159870 |
| 19 | Metabolic alkalosis (HP:0200114) | 3.01614098 |
| 20 | Hyperglycemia (HP:0003074) | 2.99229439 |
| 21 | Hepatic necrosis (HP:0002605) | 2.99145732 |
| 22 | Vascular calcification (HP:0004934) | 2.94690301 |
| 23 | Ketoacidosis (HP:0001993) | 2.91255682 |
| 24 | Limb dystonia (HP:0002451) | 2.86892487 |
| 25 | 3-Methylglutaconic aciduria (HP:0003535) | 2.85302612 |
| 26 | Palpitations (HP:0001962) | 2.84005139 |
| 27 | Progressive neurologic deterioration (HP:0002344) | 2.82522705 |
| 28 | Abnormality of vitamin metabolism (HP:0100508) | 2.79965949 |
| 29 | Hypoglycemic coma (HP:0001325) | 2.77537301 |
| 30 | Hypomagnesemia (HP:0002917) | 2.70992897 |
| 31 | Intestinal atresia (HP:0011100) | 2.68215775 |
| 32 | Respiratory failure (HP:0002878) | 2.66232605 |
| 33 | Abnormality of magnesium homeostasis (HP:0004921) | 2.65748391 |
| 34 | Ileus (HP:0002595) | 2.63791435 |
| 35 | Cerebral edema (HP:0002181) | 2.61779000 |
| 36 | Retinal dysplasia (HP:0007973) | 2.57117251 |
| 37 | Hypokinesia (HP:0002375) | 2.56585622 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.55998050 |
| 39 | Hypokalemic alkalosis (HP:0001949) | 2.49485283 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.48988506 |
| 41 | Abnormality of chloride homeostasis (HP:0011422) | 2.45720721 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.44661871 |
| 43 | Postural tremor (HP:0002174) | 2.41979985 |
| 44 | Increased circulating renin level (HP:0000848) | 2.41462001 |
| 45 | Lactic acidosis (HP:0003128) | 2.40968174 |
| 46 | Hyperaldosteronism (HP:0000859) | 2.39009854 |
| 47 | Late onset (HP:0003584) | 2.33890198 |
| 48 | Nuclear cataract (HP:0100018) | 2.31768245 |
| 49 | Abnormality of urine glucose concentration (HP:0011016) | 2.30059835 |
| 50 | Glycosuria (HP:0003076) | 2.30059835 |
| 51 | Ketosis (HP:0001946) | 2.29440900 |
| 52 | Abnormality of renal resorption (HP:0011038) | 2.27812203 |
| 53 | Optic disc pallor (HP:0000543) | 2.25832043 |
| 54 | Leukodystrophy (HP:0002415) | 2.25071746 |
| 55 | Abnormality of renin-angiotensin system (HP:0000847) | 2.24777628 |
| 56 | Syncope (HP:0001279) | 2.23923288 |
| 57 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.23383454 |
| 58 | Methylmalonic aciduria (HP:0012120) | 2.22918600 |
| 59 | Abnormal albumin level (HP:0012116) | 2.22293159 |
| 60 | Hypoalbuminemia (HP:0003073) | 2.22293159 |
| 61 | Renal salt wasting (HP:0000127) | 2.20974913 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.19060204 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18142586 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18142586 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18142586 |
| 66 | Hyperuricemia (HP:0002149) | 2.16624886 |
| 67 | Increased purine levels (HP:0004368) | 2.16624886 |
| 68 | Pancreatic fibrosis (HP:0100732) | 2.16272355 |
| 69 | Hypokalemia (HP:0002900) | 2.16232694 |
| 70 | Exercise intolerance (HP:0003546) | 2.14657605 |
| 71 | Lethargy (HP:0001254) | 2.13456475 |
| 72 | Tubular atrophy (HP:0000092) | 2.11044433 |
| 73 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.10261834 |
| 74 | Pancreatic cysts (HP:0001737) | 2.08833098 |
| 75 | Ventricular fibrillation (HP:0001663) | 2.08689192 |
| 76 | Abnormality of vitamin B metabolism (HP:0004340) | 2.08457337 |
| 77 | Increased hepatocellular lipid droplets (HP:0006565) | 2.08432442 |
| 78 | Lipid accumulation in hepatocytes (HP:0006561) | 2.07057685 |
| 79 | Hemiparesis (HP:0001269) | 2.06185671 |
| 80 | Hypoglycemic seizures (HP:0002173) | 2.05063766 |
| 81 | Hyperphosphatemia (HP:0002905) | 2.04291023 |
| 82 | Abnormality of the renal cortex (HP:0011035) | 2.03887403 |
| 83 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.03878158 |
| 84 | Abnormality of renal excretion (HP:0011036) | 2.03861488 |
| 85 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.02703429 |
| 86 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02410767 |
| 87 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02410767 |
| 88 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02410767 |
| 89 | Exocrine pancreatic insufficiency (HP:0001738) | 2.01585118 |
| 90 | True hermaphroditism (HP:0010459) | 2.01379491 |
| 91 | Chronic bronchitis (HP:0004469) | 2.00357251 |
| 92 | Rhinitis (HP:0012384) | 1.99817922 |
| 93 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.99253842 |
| 94 | Conjunctival hamartoma (HP:0100780) | 1.98580203 |
| 95 | Medial flaring of the eyebrow (HP:0010747) | 1.98255500 |
| 96 | Renal Fanconi syndrome (HP:0001994) | 1.98016441 |
| 97 | Increased serum pyruvate (HP:0003542) | 1.97231389 |
| 98 | Abnormality of glycolysis (HP:0004366) | 1.97231389 |
| 99 | Genital tract atresia (HP:0001827) | 1.95994150 |
| 100 | Atonic seizures (HP:0010819) | 1.95891262 |
| 101 | Gait imbalance (HP:0002141) | 1.95754054 |
| 102 | Abnormal tarsal ossification (HP:0008369) | 1.95128615 |
| 103 | Steatorrhea (HP:0002570) | 1.94231908 |
| 104 | Hyperphosphaturia (HP:0003109) | 1.93694869 |
| 105 | Agitation (HP:0000713) | 1.93605687 |
| 106 | Autoamputation (HP:0001218) | 1.92272760 |
| 107 | Vaginal atresia (HP:0000148) | 1.92133819 |
| 108 | Abnormality of midbrain morphology (HP:0002418) | 1.92032975 |
| 109 | Molar tooth sign on MRI (HP:0002419) | 1.92032975 |
| 110 | Myotonia (HP:0002486) | 1.91908103 |
| 111 | Proximal tubulopathy (HP:0000114) | 1.91795530 |
| 112 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91469700 |
| 113 | Congenital sensorineural hearing impairment (HP:0008527) | 1.91060284 |
| 114 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89937485 |
| 115 | Mucopolysacchariduria (HP:0008155) | 1.89937485 |
| 116 | Right ventricular cardiomyopathy (HP:0011663) | 1.89927590 |
| 117 | Congenital primary aphakia (HP:0007707) | 1.89390450 |
| 118 | Decreased circulating renin level (HP:0003351) | 1.88548888 |
| 119 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.87774931 |
| 120 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.87774931 |
| 121 | Abnormal ciliary motility (HP:0012262) | 1.87352603 |
| 122 | Goiter (HP:0000853) | 1.86947962 |
| 123 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.86827270 |
| 124 | Emotional lability (HP:0000712) | 1.86668281 |
| 125 | Nephrogenic diabetes insipidus (HP:0009806) | 1.84924004 |
| 126 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.84499024 |
| 127 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.84499024 |
| 128 | CNS demyelination (HP:0007305) | 1.83460428 |
| 129 | Polyuria (HP:0000103) | 1.83411639 |
| 130 | Muscle fiber splitting (HP:0003555) | 1.83342157 |
| 131 | Severe visual impairment (HP:0001141) | 1.82503589 |
| 132 | Dysautonomia (HP:0002459) | 1.82355984 |
| 133 | Hyperthyroidism (HP:0000836) | 1.82153964 |
| 134 | Myopathic facies (HP:0002058) | 1.81758836 |
| 135 | Exertional dyspnea (HP:0002875) | 1.81443991 |
| 136 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.80704387 |
| 137 | Hypoplasia of the fovea (HP:0007750) | 1.80704387 |
| 138 | Nephronophthisis (HP:0000090) | 1.80676386 |
| 139 | Abnormal urine output (HP:0012590) | 1.80672458 |
| 140 | Increased serum lactate (HP:0002151) | 1.79619734 |
| 141 | Alkalosis (HP:0001948) | 1.79539256 |
| 142 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.79306249 |
| 143 | Hypotension (HP:0002615) | 1.77369068 |
| 144 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.76779613 |
| 145 | Focal motor seizures (HP:0011153) | 1.75123748 |
| 146 | Increased intramyocellular lipid droplets (HP:0012240) | 1.74803451 |
| 147 | Prolonged QT interval (HP:0001657) | 1.74793495 |
| 148 | X-linked dominant inheritance (HP:0001423) | 1.72532073 |
| 149 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.71213019 |
| 150 | Ankle clonus (HP:0011448) | 1.70975237 |
| 151 | Adrenal overactivity (HP:0002717) | 1.70713948 |
| 152 | Dicarboxylic aciduria (HP:0003215) | 1.70390272 |
| 153 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70390272 |
| 154 | Sudden death (HP:0001699) | 1.68365379 |
| 155 | Methylmalonic acidemia (HP:0002912) | 1.68290758 |
| 156 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.67399056 |
| 157 | Septate vagina (HP:0001153) | 1.67274316 |
| 158 | Sensory axonal neuropathy (HP:0003390) | 1.65548405 |
| 159 | Increased muscle lipid content (HP:0009058) | 1.65407251 |
| 160 | Abnormal urine phosphate concentration (HP:0012599) | 1.64065673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 3.67472697 |
| 2 | EPHA2 | 3.33799369 |
| 3 | STK39 | 2.97333701 |
| 4 | WNK4 | 2.85169517 |
| 5 | NME1 | 2.76938706 |
| 6 | MST4 | 2.69537763 |
| 7 | OXSR1 | 2.68797962 |
| 8 | AKT3 | 2.32145548 |
| 9 | MAP4K2 | 2.28081070 |
| 10 | MAP2K2 | 2.25108691 |
| 11 | CASK | 2.22882461 |
| 12 | WNK3 | 2.08919319 |
| 13 | GRK5 | 2.04299620 |
| 14 | MAPK15 | 1.97234224 |
| 15 | MAP3K12 | 1.96805576 |
| 16 | BRAF | 1.96331482 |
| 17 | FGFR2 | 1.93689261 |
| 18 | LIMK1 | 1.84191309 |
| 19 | LMTK2 | 1.83662638 |
| 20 | NTRK1 | 1.79949241 |
| 21 | MAP3K2 | 1.77307347 |
| 22 | FRK | 1.71398305 |
| 23 | ACVR1B | 1.65707273 |
| 24 | MYLK | 1.63620246 |
| 25 | CAMK2D | 1.58159587 |
| 26 | CAMK2B | 1.52590175 |
| 27 | PHKG2 | 1.49528162 |
| 28 | PHKG1 | 1.49528162 |
| 29 | STK38L | 1.46636852 |
| 30 | MAPKAPK5 | 1.44324958 |
| 31 | CAMK2G | 1.42768082 |
| 32 | STK16 | 1.42379269 |
| 33 | TESK1 | 1.41569338 |
| 34 | BCR | 1.41418957 |
| 35 | TRIM28 | 1.35352123 |
| 36 | PNCK | 1.33328651 |
| 37 | PIK3CA | 1.33169310 |
| 38 | SGK223 | 1.31757439 |
| 39 | SGK494 | 1.31757439 |
| 40 | MST1R | 1.23895776 |
| 41 | KSR2 | 1.17645330 |
| 42 | EIF2AK3 | 1.16865639 |
| 43 | MAP2K1 | 1.15860671 |
| 44 | PDK2 | 1.15245703 |
| 45 | EIF2AK1 | 1.13533932 |
| 46 | STK3 | 1.11111845 |
| 47 | PIM2 | 1.10749039 |
| 48 | TRPM7 | 1.10580244 |
| 49 | OBSCN | 1.05840690 |
| 50 | PDK4 | 1.04602419 |
| 51 | PDK3 | 1.04602419 |
| 52 | PRKCI | 1.03958292 |
| 53 | PRKCE | 1.02835134 |
| 54 | NLK | 1.01800739 |
| 55 | FER | 0.98956497 |
| 56 | FGFR3 | 0.98027130 |
| 57 | EPHA3 | 0.96680929 |
| 58 | MET | 0.94955419 |
| 59 | CSNK1G3 | 0.93575524 |
| 60 | MAP3K9 | 0.90185090 |
| 61 | TNIK | 0.87498948 |
| 62 | MAP3K3 | 0.84591675 |
| 63 | BMPR2 | 0.83390879 |
| 64 | PRKG2 | 0.82954972 |
| 65 | TESK2 | 0.82188078 |
| 66 | CAMKK2 | 0.81153919 |
| 67 | DAPK2 | 0.79775407 |
| 68 | GRK7 | 0.79080732 |
| 69 | ZAK | 0.76754784 |
| 70 | PINK1 | 0.76715106 |
| 71 | PAK3 | 0.75966071 |
| 72 | MAPK13 | 0.75207307 |
| 73 | BCKDK | 0.74799634 |
| 74 | CAMK2A | 0.73114587 |
| 75 | CSNK1G2 | 0.71450609 |
| 76 | MINK1 | 0.71256043 |
| 77 | PTK2B | 0.71045492 |
| 78 | TNK2 | 0.69945153 |
| 79 | NTRK3 | 0.67927124 |
| 80 | DAPK3 | 0.65902917 |
| 81 | MARK1 | 0.65240522 |
| 82 | PRKG1 | 0.64782440 |
| 83 | DAPK1 | 0.64643036 |
| 84 | CSNK1G1 | 0.63904169 |
| 85 | WNK1 | 0.63835569 |
| 86 | MAP2K7 | 0.63483230 |
| 87 | STK24 | 0.62312394 |
| 88 | NEK1 | 0.60245218 |
| 89 | ERBB4 | 0.57382931 |
| 90 | BMPR1B | 0.56358051 |
| 91 | DYRK2 | 0.56256583 |
| 92 | ERBB3 | 0.55428798 |
| 93 | PLK2 | 0.55045463 |
| 94 | TAOK1 | 0.53522741 |
| 95 | MAP2K4 | 0.53298700 |
| 96 | TLK1 | 0.52860143 |
| 97 | RIPK1 | 0.52290819 |
| 98 | PRKCG | 0.52107842 |
| 99 | PRKD3 | 0.51700682 |
| 100 | PDPK1 | 0.50275827 |
| 101 | ABL2 | 0.50067529 |
| 102 | IRAK1 | 0.48984385 |
| 103 | PRKAA2 | 0.48657381 |
| 104 | STK4 | 0.48133248 |
| 105 | ADRBK2 | 0.46845878 |
| 106 | PRKACA | 0.44649200 |
| 107 | CDK14 | 0.43913531 |
| 108 | AKT2 | 0.43754190 |
| 109 | ROCK2 | 0.43430399 |
| 110 | ADRBK1 | 0.42254023 |
| 111 | CDK5 | 0.41423704 |
| 112 | MAPKAPK3 | 0.41249955 |
| 113 | IKBKB | 0.40470551 |
| 114 | SGK2 | 0.40395202 |
| 115 | MATK | 0.40287319 |
| 116 | CSNK1A1L | 0.39649887 |
| 117 | INSRR | 0.39446334 |
| 118 | YES1 | 0.39299710 |
| 119 | ROCK1 | 0.38999521 |
| 120 | RPS6KA2 | 0.38952243 |
| 121 | MAP2K6 | 0.38884995 |
| 122 | CSNK1A1 | 0.38375117 |
| 123 | EPHB2 | 0.38155075 |
| 124 | PIK3CG | 0.37522902 |
| 125 | GRK1 | 0.37403894 |
| 126 | MUSK | 0.36540029 |
| 127 | MAP3K4 | 0.36299617 |
| 128 | PRKCQ | 0.35898575 |
| 129 | STK11 | 0.35498472 |
| 130 | PRKAA1 | 0.35222190 |
| 131 | MAP3K1 | 0.35106162 |
| 132 | PRKCA | 0.34422180 |
| 133 | PKN1 | 0.34371525 |
| 134 | MKNK2 | 0.31278881 |
| 135 | HIPK2 | 0.31176414 |
| 136 | ILK | 0.29737530 |
| 137 | PAK4 | 0.28096821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.48002595 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.66256588 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.14775373 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.03824892 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.82877547 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.47133943 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.16100908 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.08253700 |
| 9 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.99493154 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.96743026 |
| 11 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.92062540 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.85524453 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.82892634 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81955036 |
| 15 | Protein export_Homo sapiens_hsa03060 | 1.76364119 |
| 16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.73335970 |
| 17 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.71806219 |
| 18 | Mineral absorption_Homo sapiens_hsa04978 | 1.68566015 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 1.53568325 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.53206659 |
| 21 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.46412829 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46103544 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45987883 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44302015 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.41260475 |
| 26 | Circadian rhythm_Homo sapiens_hsa04710 | 1.36757411 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27812567 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.26250481 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26079733 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.20433398 |
| 31 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.19667414 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.18498789 |
| 33 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18226380 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.17449613 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16731858 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16440559 |
| 37 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.12822683 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12216855 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.11996508 |
| 40 | Taste transduction_Homo sapiens_hsa04742 | 1.10641398 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09622890 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.09284354 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07244179 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04954873 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04237908 |
| 46 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03922614 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02895667 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 1.02875510 |
| 49 | Tight junction_Homo sapiens_hsa04530 | 1.01473160 |
| 50 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00123536 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00096920 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99847813 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99433566 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.98620452 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97964706 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96085053 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.95692451 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95325098 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94579732 |
| 60 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93809032 |
| 61 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91385269 |
| 62 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90415555 |
| 63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88602335 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87503325 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86987159 |
| 66 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.86104627 |
| 67 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.86039081 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84450992 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83862302 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83858149 |
| 71 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82852994 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82555852 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.80784765 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.79173572 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.77079376 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.76040766 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76033195 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75964242 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75571925 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75466720 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74435686 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.74188076 |
| 83 | Phototransduction_Homo sapiens_hsa04744 | 0.73442851 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.72172234 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72078483 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71657303 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70426719 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70335502 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69637172 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69314908 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.66885747 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58182477 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.57662196 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56014287 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55787057 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55447038 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55170499 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54849079 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54667661 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.53815392 |
| 101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51208827 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50904491 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50606885 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50075555 |
| 105 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.48491801 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.45537769 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.44949643 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44441884 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44107835 |
| 110 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43818998 |
| 111 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.42733569 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.42065403 |
| 113 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.41644080 |
| 114 | RNA polymerase_Homo sapiens_hsa03020 | 0.41489417 |
| 115 | Peroxisome_Homo sapiens_hsa04146 | 0.41362155 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | 0.40928751 |
| 117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40248702 |
| 118 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39505092 |
| 119 | ABC transporters_Homo sapiens_hsa02010 | 0.39346726 |
| 120 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38321898 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38198279 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37657777 |
| 123 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34735939 |
| 124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34678278 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.34583059 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.34377009 |
| 127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31117596 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.30447234 |
| 129 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30130491 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.29955545 |

